Gufic BioSciences Share Price

NSE
GUFICBIO •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Gufic BioSciences
Gufic BioSciences Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Gufic BioSciences Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
27.08% Fall from 52W High
-12.8
Dividend yield 1yr %
0.03

Gufic BioSciences Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Gufic BioSciences Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
207.79 Cr
204.18 Cr
202.81 Cr
194.99 Cr
201.78 Cr

Gufic BioSciences Yearly Revenue

Mar 2024
808.84 Cr

Gufic BioSciences Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
19.31 Cr
21.77 Cr
20.86 Cr
20.05 Cr
22.26 Cr

Gufic BioSciences Yearly Net Profit/Loss

Mar 2024
86.14 Cr
Gufic BioSciences Result Highlights
  • Gufic BioSciences Ltd reported a 2.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 3.7%.

  • Its expenses for the quarter were up by 4.8% QoQ and 6.2% YoY.

  • The net profit decreased 11.3% QoQ and decreased 13.3% YoY.

  • The earnings per share (EPS) of Gufic BioSciences Ltd stood at 1.9 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Gufic BioSciences shareholding Pattern

Promoter
72.5%
Foreign Institutions
0.3%
Mutual Funds
3.4%
Domestic Institutions
3.4%
Public
23.8%
Promoter
72.5%
Foreign Institutions
0.3%
Mutual Funds
2.9%
Domestic Institutions
3%
Public
24.2%
Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.5%
Domestic Institutions
2.5%
Public
24.8%
Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.3%
Domestic Institutions
2.4%
Public
24.9%
Promoter
72.5%
Foreign Institutions
0.1%
Mutual Funds
2.1%
Domestic Institutions
2.2%
Public
25.2%
Promoter
72.5%
Foreign Institutions
0.5%
Mutual Funds
1.6%
Domestic Institutions
1.7%
Public
25.3%

Gufic BioSciences Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
369.60
10Day EMA
362.30
12Day EMA
359.80
20Day EMA
354.10
26Day EMA
353.30
50Day EMA
361.60
100Day EMA
378.60
200Day EMA
380.30
5Day SMA
374.50
10Day SMA
361.70
20Day SMA
345.20
30Day SMA
343.10
50Day SMA
352.70
100Day SMA
398.40
150Day SMA
405.70
200Day SMA
397.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
15224 Rs
39571 Rs
Week Rs
41824 Rs
139720 Rs
Month Rs
26757 Rs
72696 Rs
Resistance & Support
370.30
Pivot
Resistance
First Resistance
377.40
Second Resistance
387.10
Third Resistance
394.20
Support
First Support
360.60
Second support
353.50
Third Support
343.80
Relative Strength Index
55.42
Money Flow Index
77.67
MACD
6.50
MACD Signal
0.99
Average True Range
20.01
Average Directional Index
28.23
Rate of Change (21)
9.09
Rate of Change (125)
-12.25

Gufic BioSciences Latest News

18 APR 2025 | Friday

Gufic Biosciences Ltd - 509079 - Updation Of Contact Details Of Registrar And Share Transfer Agent ('RTA') Of The Company

14 APR 2025 | Monday

Gufic Biosciences Ltd - 509079 - Intimation Of Appeal Filed Against Assessment Order Passed By The Assessment Unit, Income Tax Department

08 APR 2025 | Tuesday

Gufic Biosciences Ltd - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

View More

Gufic BioSciences Company background

Founded in: 1984
Managing director: Jayesh P Choksi
Gufic Biosciences (GBL) was incorporated in Jul84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 4042 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a longstanding presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market. The company plan to invest further in RD activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 202021, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.
Read More

Gufic BioSciences FAQs

Gufic BioSciences share price is ₹365.4 in NSE and ₹365 in BSE as on 30/4/2025.

Gufic BioSciences share price in the past 1-year return was 12.46. The Gufic BioSciences share hit a 1-year low of Rs. 278 and a 1-year high of Rs. 504.25.

The market cap of Gufic BioSciences is Rs. 3687.2 Cr. as of 30/4/2025.

The PE ratios of Gufic BioSciences is 44.82 as of 30/4/2025.

The PB ratios of Gufic BioSciences is 6.4 as of 30/4/2025

The Mutual Fund Shareholding in Gufic BioSciences was 3.39% at the end of 30/4/2025.

You can easily buy Gufic BioSciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Gufic BioSciences stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -